Cutting edge: Tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5377-5381

  Hayakawa, Yoshihiro ^a   Kelly, Janice M ^a   Westwood, Jennifer A ^a   Darcy, Phillip K ^a   Diefenbach, Andreas ^a   Raulet, David ^a   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD70 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR; TUMOR REJECTION;

EID: 0037111464     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5377     Document Type: Article

References (33)

1. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:41.
2. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
3. Diefenbach, A., and D. H. Raulet. 1999. Natural killer cells: Stress out. turn on, tune in. Curr. Biol. 9:R851.
4. Biassoni, R., C. Cantoni, D. Pende, S. Sivori, S. Parolini, M. Vitale, C. Bottino, and A. Moretta. 2001. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181:203.
5. Lanier, L. L. 2001. On guard: Activating NK cell receptors. Nat. Immunol. 2:23.
6. Lanier, L. L. 2000. Turning on natural killer cells. J. Exp. Med. 191:1259.
7. Campbell, K. S., and M. Colonna. 2001. Human natural killer cell receptors and signal transduction. Int. Rev. Immunol. 20:333.
8. Diefenbach, A., and D. H. Raulet. 2001. Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181:170.
9. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727.
10. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119.
11. Cerwenka, A., A. B. Bakker, T. McClanahan, J. Wagner, J. Wu, J. H. Phillips, and L. L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721.
12. Cerwenka, A., and L. L. Lanier. 2001. Ligands for natural killer cell receptors: Redundancy or specificity. Immunol. Rev. 181:158.
13. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197.
14. Smith, H. R., A. H. Idris, and W. M. Yokoyama. 2001. Murine natural killer cell activation receptors. Immunol. Rev. 181:115.
15. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV gtycoprotein UL[6 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123.
16. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323.
17. Wu, J., Y. Song, A, B. Bakker, S. Bauer, T. Spies, L. L. Lanier, and J. H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285:730.
18. Stephens, H. A. 2001. MICA and MICB genes: Can the enigma of their polymorphism be resolved? Trends Immunol. 22:378.
19. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K, H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96:6879.
20. Diefenbach, A., E. R. Jensen, A. M. Jamieson, and D. H. Raulet. 2001. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165.
21. Cerwenka, A., J. L. Baron, and L. L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-I gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98:11521.
22. van den Broek, M. F., D. Kagi, R. M. Zinkernagel, and H. Hengartner. 1995. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514.
23. Smyth, M. J., J. M. Kelly, A. G. Baxter, H. Korner, and J. D. Sedgwick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1611.
24. Smyth, M. J., K. Y. Thia, E. Cretney, J. M. Kelly, M. B. Snook, C. A. Forbes, and A. A. Scalzo. 1999. Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162:6658.
25. Street, S. E., E. Cretney, and M. J. Smyth. 2001. Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood 97:192.
26. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675.
27. Kelly, J. M., P. K. Darcy, J. L. Markby, D. I. Godfrey, K. Takeda, H. Yagita, and M. J. Smyth. 2002. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3:83.
28. Smyth, M. J., D. I. Godfrey, and J. A. Trapani. 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2:293.
29. Kelly, J. M., K. Takeda, P. K. Darcy, H. Yagita, and M. J. Smyth. 2002. A role for IFN-γ in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J. Immunol. 168:4472.
30. Girardi, M., D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday. 2001. Regulation of cutaneous malignancy by γδ T cells. Science 294:605.
31. van den Broek, M. E. D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W. K. Lutz, C. J. Melief, R. M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781.
32. Smyth, M. J., K. Y. Thia, S. E. Street, D. MacGregor, D. I. Godfrey, and J. A. Trapani. 2000. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192:755.
33. + T cells and NK cells in vivo. Nat. Immunol. 3:529.